Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rotavac immunogenicity and safety in healthy infants in Vietnam
NCT04596696Phase 3Completed
- Sponsor
- Bharat Biotech
- Start
- Dec 2017
- Primary completion
- Dec 2018
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 3 trial of rotavirus vaccine 116E in rotavirus gastroenteritis, sponsored by Bharat Biotech. Started Dec 2017; status: completed.
02
Drugs
rotavirus vaccine 116E
03
Conditions
rotavirus gastroenteritis
Beyond the preview
Go deeper on NCT04596696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04596696.